Verapamil and beta-blocker — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Bradycardia and heart block risk
Verapamil combined with a beta-blocker increases the risk of significant bradycardia and AV block. The low pulse makes this interaction clinically important before supply. In this scenario, the correct option is bradycardia and heart block risk. The other options are plausible but do not address the key clinical, legal or safety issue as directly. This aligns with UK pharmacy practice guidance cited in the reference field.
Reference: BNF; Stockley's Drug Interactions